Results 241 to 250 of about 95,141 (285)
Criteria for defining and dating onset of organ system involvement in systemic sclerosis. [PDF]
Hudson M +10 more
europepmc +1 more source
Janus kinase inhibitors in localized scleroderma: a systematic literature review. [PDF]
Şener S +4 more
europepmc +1 more source
Corrigendum to "Isolated scleroderma of the lower extremities misdiagnosed as lymphedema and presenting with scleroderma renal crisis". [PDF]
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2009
Scleroderma (systemic sclerosis) is a complex disease in which extensive fibrosis, vascular alterations, and autoantibodies against various cellular antigens are among the principal features There are two major subgroups in the commonly accepted classification of scleroderma: limited cutaneous scleroderma and diffuse cutaneous scleroderma.
Gabrielli A. +2 more
openaire +4 more sources
Scleroderma (systemic sclerosis) is a complex disease in which extensive fibrosis, vascular alterations, and autoantibodies against various cellular antigens are among the principal features There are two major subgroups in the commonly accepted classification of scleroderma: limited cutaneous scleroderma and diffuse cutaneous scleroderma.
Gabrielli A. +2 more
openaire +4 more sources
Rheumatic Disease Clinics of North America, 1989
This article reviews the literature on scleroderma and pregnancy, highlighting its sparsity, confused state, and retrospective nature. It emphasizes the need for more informed prospective work. This is required for clinical management and to help understand the complex interaction between scleroderma and pregnancy.
C M, Black, W M, Stevens
openaire +2 more sources
This article reviews the literature on scleroderma and pregnancy, highlighting its sparsity, confused state, and retrospective nature. It emphasizes the need for more informed prospective work. This is required for clinical management and to help understand the complex interaction between scleroderma and pregnancy.
C M, Black, W M, Stevens
openaire +2 more sources
Current Opinion in Rheumatology, 2006
Localized scleroderma, also known as morphoea, has a variety of clinical manifestations that can include systemic involvement. Early recognition, diagnosis and treatment may improve the long-term outcome.A large multicentre study coordinated by the Pediatric Rheumatology European Society has yielded important information on the epidemiology and ...
Ronald M, Laxer, Francesco, Zulian
openaire +2 more sources
Localized scleroderma, also known as morphoea, has a variety of clinical manifestations that can include systemic involvement. Early recognition, diagnosis and treatment may improve the long-term outcome.A large multicentre study coordinated by the Pediatric Rheumatology European Society has yielded important information on the epidemiology and ...
Ronald M, Laxer, Francesco, Zulian
openaire +2 more sources
Best Practice & Research Clinical Rheumatology, 1995
In practice, the classification of scleroderma is less problematic than that of most other connective tissue diseases given the distinctive pattern of skin involvement. Classification of early and limited disease is more problematic and is difficult to separate from severe forms of Raynaud's phenomenon. Division of scleroderma into two groups depending
openaire +2 more sources
In practice, the classification of scleroderma is less problematic than that of most other connective tissue diseases given the distinctive pattern of skin involvement. Classification of early and limited disease is more problematic and is difficult to separate from severe forms of Raynaud's phenomenon. Division of scleroderma into two groups depending
openaire +2 more sources
Scleroderma (sect. Scleroderma) sect. Scleroderma
Published as part of Yang, Kun L., Lin, Jia Y., Li, Guang-Mei & Yang, Zhu L., 2025, Updates of Scleroderma (Basidiomycota, Boletales): new data from 18 selected species in China, pp.Yang, Kun L. +3 more
openaire +1 more source

